|
| BP-1-102 Basic information |
Product Name: | BP-1-102 | Synonyms: | BP-1-102;4-(N-(4-Cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydr;STAT3 Inhibitor XVIII, BP-1-102;BP-1-102; BP1-102; BP 1-102.;4-(N-(4-cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid;STAT3 Inhibitor XVIII;STAT3 INHIBITOR XVIII;BP1-102;BP 1-102;Benzoic acid, 4-[[(4-cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-2-hydroxy- | CAS: | 1334493-07-0 | MF: | C29H27F5N2O6S | MW: | 626.59 | EINECS: | | Product Categories: | API | Mol File: | 1334493-07-0.mol | |
| BP-1-102 Chemical Properties |
Boiling point | 749.2±70.0 °C(Predicted) | density | 1.474±0.06 g/cm3(Predicted) | storage temp. | Inert atmosphere,Store in freezer, under -20°C | solubility | DMSO:15.0(Max Conc. mg/mL);23.9(Max Conc. mM) | form | A crystalline solid | pka | 3.15±0.10(Predicted) | color | White to off-white |
| BP-1-102 Usage And Synthesis |
Uses | BP-1-102 is a potent and selective STAT3 inhibitor. STAT3 is a cytoplasmic transcription factor that induces the expression of genes related to tumorigenesis. BP 1-102 exhibits antitumor activity against Waldenstrom macroglobulinemia, a rare form of B cell non-Hodgkin lymphoma. |
| BP-1-102 Preparation Products And Raw materials |
|